During a Case-Based Roundtable® event, Saad Z. Usmani, MD, FACP, MBA, discussed quality of life and the future with CAR ...

Although myeloma is treatable, it is generally not curable, and advanced therapies like blood stem cell transplantation can ...

Multiple Myeloma is a type of blood cancer that develops in plasma ... This disease affects the bone marrow, weakening the ...

Johnson & Johnson seeks US & EU approvals for Darzalex Faspro/Darzalex as subcutaneous monotherapy for high-risk smoldering multiple myeloma: Raritan, New Jersey Monday, November ...

Early treatment with intravenous bisphosphonates at first radiographic evidence of bone lesions ... or multiple myeloma. Treatments such as radiation therapy to palliate bone pain or surgery ...

Common symptoms of multiple myeloma include bone pain in the back and ribs; broken bones, usually in the spine; feeling weak or tired; excessive thirst; frequent infections and fevers; weight loss; ...

It may be possible to collect nearly three times as many stem cells for sickle cell gene therapy with motixafortide than ...

Multiple Myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health ...

GSK is carving out a niche for Blenrep in the second-line multiple myeloma setting, for which it projects multi-blockbuster ...

Our additional preliminary studies demonstrate that dual targeting of multiple myeloma cells and BM-CAFs by CAR-T cells is ...

Don M. Benson, MD, PhD, has cared for patients at James Cancer Hospital in Ohio for 22 years, where he and his team see approximately 10,000 patient visits each year.